Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-2 of 2
Maria Jiménez
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response
Available to PurchaseInês Gomes, Maria Martelo, Rúben D. Vilela, María Jiménez, Eva M. Trinidad, Jorge Gómez-Miragaya, Eva González-Suárez, Érica Martins, Sofia S. Torres, Patrícia Corredeira, Joana L. Miranda, André Mansinho, Sofia Torres, Catarina Abreu, Rita Sousa, Sandra Casimiro, Luís Costa
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF13.
Published: 12 June 2025
Includes: Supplementary data
Journal Articles
Laura L. Vollmer, Maria Jiménez, Daniel P. Camarco, Wei Zhu, Hikmat N. Daghestani, Raghavan Balachandran, Celeste E. Reese, John S. Lazo, Neil A. Hukriede, Dennis P. Curran, Billy W. Day, Andreas Vogt
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (6): 994–1006.
Published: 08 June 2011
Includes: Supplementary data